LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 33.80 | 21.74 | 1146 | 2381 | 0.4812 | 0.7953 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 33.80 | 21.74 | 1173 | 2381 | 0.4926 | 0.8015 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 35.77 | 21.74 | 63 | 2602 | 0.0242 | 0.1666 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 35.77 | 21.74 | 958 | 2602 | 0.3681 | 0.7304 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 35.77 | 21.74 | 1169 | 2602 | 0.4491 | 0.7810 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 35.77 | 21.74 | 1189 | 2602 | 0.4568 | 0.7854 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 37.74 | 21.74 | 57 | 2828 | 0.0202 | 0.1471 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 37.74 | 21.74 | 961 | 2828 | 0.3398 | 0.7151 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 37.74 | 21.74 | 1159 | 2828 | 0.4098 | 0.7614 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 37.74 | 21.74 | 1179 | 2828 | 0.4168 | 0.7657 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 39.71 | 21.74 | 78 | 3084 | 0.0253 | 0.1957 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 39.71 | 21.74 | 964 | 3084 | 0.3126 | 0.6997 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 39.71 | 21.74 | 1174 | 3084 | 0.3807 | 0.7472 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 39.71 | 21.74 | 1194 | 3084 | 0.3871 | 0.7514 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 41.68 | 21.74 | 113 | 3418 | 0.0331 | 0.2534 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 41.68 | 21.74 | 988 | 3418 | 0.2890 | 0.6871 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 41.68 | 21.74 | 1172 | 3418 | 0.3428 | 0.7271 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 41.68 | 21.74 | 1193 | 3418 | 0.3490 | 0.7313 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 43.65 | 21.74 | 113 | 3754 | 0.0301 | 0.2483 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 43.65 | 21.74 | 975 | 3754 | 0.2597 | 0.6682 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 43.65 | 21.74 | 1180 | 3754 | 0.3143 | 0.7116 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 43.65 | 21.74 | 1199 | 3754 | 0.3194 | 0.7153 | MN20160310_N01 | K06 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 45.62 | 21.74 | 115 | 4150 | 0.0277 | 0.2459 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 45.62 | 21.74 | 968 | 4150 | 0.2332 | 0.6504 | MN20160310_N01 | E15 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 45.62 | 21.74 | 1191 | 4150 | 0.2869 | 0.6962 | MN20160310_N01 | K06 |